Training Nigerian Radiologists in Mobile Health Ultrasound-Guided Breast Biopsy for Breast Cancer Diagnosis
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-08-27
600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to train Nigerian radiologists to perform ultrasound-guided breast biopsies on women presenting with suspicious breast masses. The study evaluates the accuracy of these biopsies compared to the standard surgical excision method. The training program, developed by experts from Nigeria and the United States, certifies radiologists to safely conduct these biopsies, addressing the current limitations in Nigerian hospitals where blind biopsies or surgical excisions are common.
The study involves a competency-based mobile health ultrasound-guided breast biopsy training program for Nigerian radiologists. Women with suspicious solid breast masses will undergo ultrasound-guided biopsies performed by these trained radiologists. This approach contrasts with typical practices in Nigeria, aiming to improve diagnostic accuracy and reduce the need for surgical excision. The program certifies radiologists before they perform biopsies on patients.
Participants include women aged 18 and older with suspicious breast masses identified via ultrasound. Researchers will monitor biopsy accuracy against surgical excision results and track complication rates over 12 months. The study provides training, biopsy procedures, and follow-up assessments to evaluate safety and effectiveness. Participation involves receiving the ultrasound-guided biopsy and undergoing outcome evaluations during the study period.
CONDITIONS
Brief Title
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
Research Team
A
Adeleye Omisore, MD
E
Elizabeth Sutton, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Breast ultrasound showing a solid mass suspicious for cancer
Mass that would typically undergo blind biopsy or surgical excision at the Nigerian hospital
You will not qualify if you...
Unwilling to sign consent
Under 18 years of age
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Training and Biopsy
Duration - Up to 12 months
Nigerian radiologists complete a competency-based mobile health ultrasound-guided breast biopsy training program. Women with suspicious breast masses receive ultrasound-guided biopsies performed by these trained radiologists instead of traditional biopsy methods.
Multiple visits for training and biopsy procedures
Outcome Assessment
Duration - 12 months
Researchers monitor biopsy accuracy compared to surgical excision and track complication rates over a 12-month period.
Follow-up visits during 12 months for outcome evaluations
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Studying Key Non-coding RNAs and Their Interaction With Chromatin Remodeling in Breast Cancer Patients
Comparing 18F-FDG and 68Ga-FAPI-46 PET Scans in Women With ER-positive Breast Cancer
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Observational Study Comparing 3D and 2D Echocardiography for Early Heart Damage Detection in Patients Receiving Anthracyclines and HER2-Targeted Cancer Therapies
Study Comparing 3D-Printed Biodegradable Breast Implants, Traditional Breast-Conserving Surgery, and Silicone Implant Reconstruction for Breast Cancer Patients
Ultrahypofractionated 5-Session Whole Breast Radiotherapy with Boost versus Standard 15-Session Radiotherapy for Breast Cancer Patients with Unfavorable Characteristics
Phase II Study Comparing 5-Day vs. 9-Day Whole Breast Radiotherapy with Boost in Early-stage Breast Cancer
Evaluating 68Ga-FAPI PETCT for Checking Axillary Lymph Node Status After Neoadjuvant Therapy in Women with Breast Cancer
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Exploratory Study of 68Ga-SorB PETCT Imaging to Diagnose Sortilin-Positive Solid Tumors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
A Competency-Based Ultrasound-Guided Breast Biopsy Training Program for Radiologists From Low-and-Middle-Income Countries that Leverages Mobile Health Technology (NCT04501419): A Study Protocol.